Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
Scope of the Report:
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
In the last several years, Global market of Carbocisteine developed steady, with an average growth rate of 5.2%. In 2016, Global Revenue of Carbocisteine is nearly 35 M USD; the actual production is about 1600 MT.
The classification of Carbocisteine includes 98.5% and >98.5%, and the sales proportion of >98.5% in 2016 is about 76.2%.
Carbocisteine is widely used to make drugs, the formal of drugs include Oral Solution, Tablet & Capsule and Other. The most proportion of Carbocisteine formal is Tablet & Capsule and the proportion in 2016 is about 74%.
China is the largest supplier of Carbocisteine, with a revenue market share nearly 46% in 2016. India is the second largest supplier of Carbocisteine, enjoying revenue market share nearly 25% in 2016.
Europe is the largest consumption place, with a consumption market share nearly 33% in 2016. Following Europe, China is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Wuhan Grand Hoyo, Moehs Iberica, Afton Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Carbocisteine is expected to grow at a CAGR of roughly 4.3% over the next five years, will reach 57 million US$ in 2024, from 44 million US$ in 2019, according to a new study.
This report focuses on the Carbocisteine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Wuhan Grand Hoyo
Moehs Iberica
Afton Pharma
Jinshi Pharm
Hengkang Pharma
Globe Quimica
Xiangyu Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
0.985
>98.5%
Market Segment by Applications, can be divided into
Oral Solution
Tablet & Capsule
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Carbocisteine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carbocisteine, with price, sales, revenue and global market share of Carbocisteine in 2017 and 2018.
Chapter 3, the Carbocisteine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbocisteine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Carbocisteine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Carbocisteine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
In the last several years, Global market of Carbocisteine developed steady, with an average growth rate of 5.2%. In 2016, Global Revenue of Carbocisteine is nearly 35 M USD; the actual production is about 1600 MT.
The classification of Carbocisteine includes 98.5% and >98.5%, and the sales proportion of >98.5% in 2016 is about 76.2%.
Carbocisteine is widely used to make drugs, the formal of drugs include Oral Solution, Tablet & Capsule and Other. The most proportion of Carbocisteine formal is Tablet & Capsule and the proportion in 2016 is about 74%.
China is the largest supplier of Carbocisteine, with a revenue market share nearly 46% in 2016. India is the second largest supplier of Carbocisteine, enjoying revenue market share nearly 25% in 2016.
Europe is the largest consumption place, with a consumption market share nearly 33% in 2016. Following Europe, China is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Wuhan Grand Hoyo, Moehs Iberica, Afton Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Carbocisteine is expected to grow at a CAGR of roughly 4.3% over the next five years, will reach 57 million US$ in 2024, from 44 million US$ in 2019, according to a new study.
This report focuses on the Carbocisteine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Wuhan Grand Hoyo
Moehs Iberica
Afton Pharma
Jinshi Pharm
Hengkang Pharma
Globe Quimica
Xiangyu Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
0.985
>98.5%
Market Segment by Applications, can be divided into
Oral Solution
Tablet & Capsule
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Carbocisteine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carbocisteine, with price, sales, revenue and global market share of Carbocisteine in 2017 and 2018.
Chapter 3, the Carbocisteine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbocisteine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Carbocisteine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Carbocisteine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
